Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development

Journal of Clinical Gastroenterology

Volumn 27, Issue SUPPL. 1, 1998, Pages

  Sawaoka, Hitoshi ^a   Kawano, Sunao ^a   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Murata, Hiroaki ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cell proliferation; Cyclooxygenase 2; Gastric cancer cells; NSAIDs

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER PREVENTION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN SYNTHESIS INHIBITION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0032445736     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199800001-00009     Document Type: Conference Paper

References (35)

1. Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 1996;23:379-87.
2. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin/cyclooxygenase gene. J Biol Chem 1992;267:7991-4.
3. Bazan NA, Fletcher BS, Herschman HR, et al. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA 1994;91:5252-6.
4. Ristimäki A, Garfinkel S, Wessendorf J, et al. Induction of cyclooxygenase-2 by interleukin-1-alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994;269:11769-75.
5. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Left 1993;330:156-60.
6. DuBois RN, Tsujii M, Bishop P, et al. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266:G822-7.
7. DuBois RN, Awad J, Morrow J, et al. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994;93:493-8.
8. Tsuji S, Kawano S, Sawaoka H. et al. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostagland Leukotrienes Essent Fatty Acids 1996;55:179-83.
9. Sawaoka H, Tsuji S, Tsujii M, et al. Expression of the cyclooxygenase-2 gene in gastric epithelium. J Clin Gastroenterol 1997;25(suppl 1):S105-10.
10. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107: 1183-8.
11. Gustafson-Svaerd C, Lilja I, Hallboeoek O, et al. Cyclooxygenase-1 and -2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumors in rats. Gut 1996;38:79-84.
12. Ristimäki A, Honkanen N, Jänkälä H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
13. Futaki N, Takahashi S, Yokoyama M, et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-9.
14. Gierse JK, Hauser SD, Creely DP, et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995;305:479-84.
15. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994;91: 3228-32.
16. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
17. Gold R. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25.
18. Sawaoka H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998; 274:G1061-7.
19. Kargman S, O'Neil G, Vickers P, et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
20. Santro MG, Philpott GW, Jaffe BM. Inhibition of tumor growth in vivo and in vitro by prostaglandin E. Nature 1976; 263:777-9.
21. 2, a potential antineoplastic agent. Biochem Biophys Res Commun 1982;105:956-64.
22. 2, exerting cell growth inhibition. Biochem Biophys Res Commun 1985;127:739-45.
23. 2 in human and murine melanoma cells in culture. Cancer Res 1986;46:1688-93.
24. Shimakura S, Boland CR. Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. Cancer Res 1992;52:1744-9.
25. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS 10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 1994;269:15473-80.
26. Kemppainen H, Raiha I, Sourander L. Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal antiinflammatory drugs. Hepatogastroenterology 1997;44:1143-6.
27. Nishikawa A, Kase Y, Hayakawa T, et al. Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine. Carcinogenesis 1997;18:1259-63.
28. Qiao L, Shiff SJ, Rigas B. Sulindac sulfide inhibits the proliferation of colon cancer cells diminished expression of the proliferation markers PCNA and Ki-67. Cancer Lett. 1997; 115:229-34.
29. Jack DB. One hundred years of aspirin. Lancet 1997;350: 437-9.
30. Narisawa T, Sato M, Tani M, et al. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981;41:1954-7.
31. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987;47:5340-6.
32. Thun MJ, Namboodiri MM, Heath CWJ. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325: 1593-6.
33. Müller AD, Sonnenberg A, Wasserman IH. Diseases preceding colon cancer. A case control study among veterans. Dig Dis Sci 1994;39:2480-4.
34. Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
35. Sato H, Inada I, Hirata T, et al. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 1981;81: 719-25.